Feasibility Study of a Behavioral Parent Intervention to Support Self-management in Pediatric Typ 1 Diabetes
Launched by KAROLINSKA INSTITUTET · Sep 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new program designed to help parents support their children, aged 9 to 14, who have type 1 diabetes. The goal of the study is to see if this behavioral intervention can make it easier for families to manage their daily routines related to diabetes care. The program focuses on improving the relationship between parents and children when it comes to managing diabetes, making it a team effort.
To participate, parents or guardians must have a child who has been diagnosed with type 1 diabetes for at least a year and is currently receiving care at one of three diabetes clinics in the Stockholm area. Parents should feel that they are struggling with daily management and communication about diabetes, but these difficulties should not be purely about medical issues like insulin dosing. It's also important that parents can understand and communicate in Swedish and are motivated to attend group meetings. Participants can expect to join supportive group sessions that aim to strengthen their skills in helping their child manage diabetes better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parents/guardians of children aged 9-14 with type 1 diabetes.
- • The child has had type 1 diabetes for at least one year.
- • The parent experience difficulties in managing daily life and/or the parent-child collaboration around self-management routines.
- • The perceived difficulties should not solely be due to perceived problems in the medical aspects of the diabetes treatment, such as a perceived need for more support in insulin dosing, more diabetes education, or technical/medical support. This criterion is based solely on the subjective judgement of the parent him-/herself.
- • The child receives diabetes care at one of the three diabetes clinics in the Stockholm Region.
- • The parent speaks, understands, and can read Swedish.
- • The parent claims to be motivated and has the practical possibility to participate in the study and attend group meetings.
- Exclusion Criteria:
- • The parent reports current and severe psychiatric conditions in themselves or the child that need to be prioritized, such as severe depression, suicidal thoughts/self-harm, psychosis, or mania.
- • The parent is involved in another psychological treatment of a behavior-changing nature that is in an active phase, either concerning themselves or a child.
- • Major planned changes in diabetes treatment that require learning and behavioral changes, such as transitioning from pen to pump, and that are expected to occur during the first 3.5 months of the study (active intervention phase).
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Brjánn Ljótsson, Professor
Principal Investigator
Karolinska Institute, Department of Clinical Neuroscience, Division of Psychology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported